Heart diseases are responsible for nearly 18 million deaths annually, according to the World Health Organization (WHO). Atherosclerosis, characterized by plaque buildup in arteries, is a significant contributor to these conditions. This process restricts blood flow, raising the risk of heart attacks and strokes. Traditional diagnostic methods often identify atherosclerosis only after significant plaque accumulation, highlighting the need for advanced technology in its diagnosis and treatment.
Recent developments in artificial intelligence (AI) and nanotechnology are paving the way for less invasive, targeted approaches to managing atherosclerosis. AI helps predict disease progression and personalize treatments based on individual patient data. Simultaneously, wearable technology enables continuous heart health monitoring.
Researchers at the National University of Singapore have developed a nanoparticle technology for targeted diagnosis and treatment of atherosclerosis. This innovative approach involves nanoparticles that degrade in the acidic environment of atherosclerotic plaques, releasing gadolinium for real-time imaging and Simvastatin for anti-inflammatory treatment. This dual action aims to stabilize plaques and reduce cardiovascular risks.